CCO Infectious Disease Podcast
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
- Update frequency
- every 3 days
- Average duration
- 25 minutes
- Episodes
- 461
- Years Active
- 2020 - 2025
Key Decisions in HIV Care: Is There a Role for PIs in Current Practice?
In this episode, Karen Ha, MD, explores recommendations and data on the role of PIs in current practice.
Listen as she gives her perspectives on:
- DHHS guideline recommendations on the use of PI-based A…
COVID-19 Oral Antiviral Agents
In this episode, Renslow Sherer, MD, discusses key data on COVID-19 oral antiviral agents—molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir—for nonhospitalized adults with mild to moderate C…
Key Decisions in HIV Care: Is There a Role for NNRTIs in Current Practice?
In this episode, Karen Ha, MD, explores recommendations and data on the role of NNRTIs in current practice.
Listen as she gives her perspectives on:
- DHHS guideline recommendations on the use of NNRTI-b…
Personal Perspectives on HIV PrEP Use: My Decision, My Experience
In this episode, Christian R. Pollard provides his perspectives as an individual taking daily oral HIV PrEP, including factors he considered in the decision to use PrEP, his experience with taking Pr…
Key Decisions in HIV Care: Choosing ART in the Context of Virologic Failure and Resistance
In this episode from the series “Key Decisions in HIV Care,” W. David Hardy, MD, and Josep M. Llibre, MD, PhD, discuss important considerations for ART use in the context of virologic failure and res…
Individualized Choices in Antiretroviral Therapy: Present and Future
Hear insights from 3 faculty experts as they present emerging data and guidelines and engage in discussion on patient-centered ART selection for people with HIV.
Topics include assessing treatment opt…
Key Decisions in HIV Care: Polypharmacy and Cardiovascular Risk Considerations in Older PWH
In this episode from the series “Key Decisions in HIV Care,” Jonathan Appelbaum, MD, FACP, AAHIVS, and Jens D. Lundgren, MD, DMSc, discuss important considerations for ART use in older PWH, including…
Universal Screening for Hepatitis Delta
Hepatitis delta is the most severe form of viral hepatitis, and many patients remain undiagnosed. In this episode, Maria Buti, MD, and Robert G. Gish, MD, discuss the prevalence and severity of hepat…
Key Decisions in HIV Care: Assessing Candidacy for Long-Acting ART
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores recommendations and data on patient specific factors associated with LA CAB plus RPV failure.
Listen as she gives her perspectives …
Tackling Racial Inequalities in HBV Care Globally
In this episode, Geoffrey Dusheiko, FRCP, FRCP (Edin), FCP (SA), and Ming-Lung Yu, MD, PhD, discuss key racial inequities of care that lead to undertreatment for migrant populations and other racial …
Shingles in the COVID-19 Era: Increasing Shingles Vaccine Uptake—Audio Recap
In this episode, Dalilah Restrepo, MD, discusses barriers to shingles vaccination and strategies to increase routine vaccine uptake in the COVID-19 era.
Using the latest data and expert guidance, this…
COVID-19 Vaccination: Third Doses and Boosters
In this episode, Renslow Sherer, MD, discusses key data on COVID-19 vaccine efficacy, including:
- Third doses
- Booster doses
- Mixing and matching booster doses
Presenter:
Renslow Sherer, MD
Director, Internat…
Key Studies on Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021
In this episode, Martin C. Mahoney, MD, PhD, discusses new data on vaccine-preventable diseases from IDWeek 2021, including:
- Pneumococcal disease
- Respiratory syncytial virus (RSV)
- Herpes zoster
- Influenza
…
Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021
In this episode, Nancy Reau, MD, discusses new viral hepatitis data from AASLD 2021, including:
- HBV treatment in pregnancy
- Outcomes following HBV treatment withdrawal
- Progress toward an HBV cure
- HCV im…
Key Studies Influencing My Practice Following EACS 2021—Audio Recap
In this episode, Tristan J. Barber, MA, MD, FRCP, discusses new HIV data from EACS 2021, including:
- First-line therapies
- BIC/FTC/TAF in a test-and-treat model in IMEA 055 FAST
- Week 144 data of ISL + DOR…
Shingles in the COVID-19 Era: Vaccination for Prevention of Complications—Audio Recap
In this episode, Dalilah Restrepo, MD, discusses expert guidance on vaccination for the prevention of shingles complications in the COVID-19 era. Contributor: Dalilah Restrepo, MD |
Key Decisions in HIV Care: Managing Suboptimal CD4+ Cell Count Increase Despite Suppressive ART
In this episode, William R. Short, MD, MPH, AAHIVS, explores recommendations and data on strategies to address suboptimal CD4+ cell count response in people with HIV on suppressive ART.
Listen as he g…
Tackling Racial Disparities in HCV Care: Global Edition
In this episode, Prof Ashley Brown, BSc, MD, FRCP, and Ahmed M. Elsharkawy, PhD, FRCP(UK), discuss key racial inequities of care that lead to undertreatment for migrant populations and other racial m… |
Emerging Insights on Adverse Events During ART and Implications for Treatment: Nephrotoxicity and Long-Acting Injectables
In this episode, Fidelia Bernice, PharmD, and Aadia I. Rana, MD, share insights on HIV ART safety and tolerability including recent data on nephrotoxicity and the use of NRTI-sparing regimens with di…
Shingles in the COVID-19 Era: Shingles Vaccination Guidelines—Audio Recap
In this episode, Tracy Zivin-Tutela, MD, discusses expert guidance on vaccination against shingles.
Tracy Zivin-Tutela, MD
Infectious Diseases Specialist
Department of Infectious Diseases
Fountain Valley…